Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind

Page created by Herbert Rowe
 
CONTINUE READING
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Swedencare

Presentation
CEO Håkan Lagerberg
CFO Jenny Graflind
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Swedencare Summary
• An Animal Health care company with global presence in a fast growing market
• Sales in 50 countries, both with fully owned subsidiaries and external distributors
• ProDen PlaqueOff® – a world leading product within oral care– complemented by
  a wide range of nutraceuticals (NutriScience)
• Own production facility on Ireland with a wide product offering
• A fragmented market – continued expansion through acquisitions
• High growth and profitability
• Listed On NASDAQ First North since 14 June 2016
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Pets – from something you own to
a member of the family
 • 68% of US households have a pet - increased every
   year over two decades
 • 94% sees the pet as a family member
 • The pets live longer – age related symptoms increase
 • Increased demand for organic feed and nutraceuticals
 • Demand of premium products grows
 • 46% of the pet owners have bought a nutraceutical at
   least once
 *) USA
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Swedencare and the
                                                                       Headcount:
                                                                       Swedencare AB: 5
                                                                       Biodistra: 1

World
                                                                       Swedencare Nordic: 1
                                                                       Swedencare UK: 4
                                                                       Swedencare Ireland: 12
                                                                       Swedencare US: 4
                                                                       Swedencare Buccosanté: 2

                                                 180 million pets in
                                                 Europe
                                                                           70M+ pets in
                                                                           China/Japan

                                                                       Pet market in China
                          Nutraceuticals, 2500
170 million pets in the                                                grows by double digits.
                          MUSD in Europe and
U.S.                                                                   Both by number of pets
                          USA – Growth 10–
                                                                       and spending
                          15% per year
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Dog - Cat - Horse
            NUTRACEUTICALS

                 FEED

   ACCESSORIES          PRESCRIBED PRODUCTS
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Company Timeline

1990’s                                                                                                                2017 (March)
                                                       2006
Research & discovery       2001                                          2016 (January)                               Production of
                                                       Patents in                                 2016 (July)
of advantages of           Swedencare start                              Swedencare acquire                           PlaqueOff in own
                                                       Europe and USA                             Swedencare
product                    selling within the                            former distributors in                       factory in Ireland
                                                       are registered                             acquire Biodistra
                           Nordic                                        France, UK and USA
                                                                                                  AB

                             2005                                             2016 (June)         2016 (November)          2018 (January)
2000                                                       2015
                             International expansion                          Company is listed                            Conversion to IFRS
Establishment of current                                   New Business                           Swedencare acquire
                             in Europe is launched                            on Nasdaq First                              (International
business of Swedencare                                     Plan developed                         the Irish company
                                                                              North                                        Financial Reporting
                                                           with new owners                        NutriScience (Ecuphar
                                                                                                                           Standard)
                                                                                                  Ltd.)
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Strategy in three parts

                   Product Portfolio and
  Distribution                             Marketing
                        Channels

                       PlaqueOff           *B2C and B2B
 5 Sales Offices
                      NutriScience          Exhibitions
       >25
                      New products          *Distributor
  distributors
                                              support
   Sales in 50
                                             *Training
    countries
                                              *Digital
                           Vet
                         Pet retail
                        Pharmacies
                          Retail
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Proden PlaqueOff – a leading
oral health product
• Systemic effect on Oral Health
• Patent- and Trade mark protected in all our major markets
• Several clinical studies
• Marketed in several sizes and forms – powder, Dental Bites, Dental Bone, in feed ( fall 2017)
• 1,4million pots, annual consumption for 0,5 million dogs. Approx. 409 million registered dogs
  in the world means that we reach 0,12% of the potential market
• Retail value, over 35 MUSD
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
New products
NutriScience by Swedencare for dogs and cats
A new group of products within several focus areas for dogs and cats.
•   Joints and mobility
•   Skin and coat
•   Multivitamin supplement
•   Calming supplement

NutriScience by Swedencare for horses
We are expanding the selection and we are now able to offer products which also soothes and
prevents common problems with horses.
•   Digestive supplement
•   For a healthy stomach
•   For strength and performance
•   Cooling gel
•   Salt replacement
Swedencare Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Clinical Studies – VOHC
The difference between the placebo product and the tested
product (ProDen PlaqueOff®) was 30-70%

P1 Placebo
P2 ProDen PlaqueOff®
Key Performance Indicators – Q1 2018

                             EBIT
   REVENUE                                          SOLVENCY
                           6 012 Tkr
  21 798 Tkr                 27,6%                   75,9 %

               CHANGE IN                 CASH
               REVENUES
                -4,9%                  22 624 Tkr
Key Performance Indicators
                               jan-mar      jan-mar       jan-dec
(TSEK)                            2018         2017          2017

Net Revenue                      21 685       22 910       85 490
Total Revenue                    21 798       22 910       85 660
EBIT                              6 012        6 951       21 896
Net Income                        4 801        5 236       17 014
Balance Sheet Total             105 448       94 772       99 848
Equity                           80 007       61 939       74 203
Change of Revenue (%)             -4,9%        64,1%        58,2%
Gross Margin (%)                  73,0%        73,0%        74,4%
EBIT-margin (%)                   27,6%        30,3%        25,6%
Net Income margin (%)             22,0%        22,9%        19,9%
Solvency (%)                      75,9%        65,4%        74,3%
Interestbearing netdebt          -4 626        4 415       -6 013
Cash                             22 624       19 373       24 077
Outstanding Shares           15 770 622   15 770 622   15 770 622
Average outstanding shares   15 770 622   15 770 622   15 770 622
Net Income per share (SEK)         0,30         0,33         1,08
Equity per share (SEK)             5,07         3,93         4,71
Rolling 4 Quarters - Sales
Rolling 4 Quarters - EBITDA
Sales per Region

Q1 2018                Q1 2017
Sales per Product

Q1 2018                Q1 2017
Swedencare Group – Balance Sheet March 2017
                               31-mar    31-dec   31-mars
                                 2018     2017       2017

Goodwill                        49 848   49 848    49 848
Other intangible assets            461      515       816
Buildings and land               3 385       14        36
Tangible assets                  3 176    3 034     1 781
Financial assets                   530      635       645

Total non current assets        57 400   54 046    53 126
Inventory                        9 190    8 236     7 151
Accounts receivable             14 494   10 374    13 351
Other ST receivables             1 740    3 115     1 771
Cash                            22 624   24 077    19 373
Total current assets            48 048   45 802    41 646
TOTAL ASSETS                   105 448   99 848    94 772

Total equity                    80 007   74 203    61 939

Long term liabilities            9 998   10 064    15 540
Creditline                           -        -       248
Accounts payable                 2 874    1 859     2 956
Other ST Liabilities            12 569   13 722    14 089
Total liabilities               25 441   25 645    32 833

TOTAL EQUITY AND LIABILITIES   105 448   99 848    94 772
Stock Trend Over Time

Introduction price: 14 SEK
Owners 2018-03-31                                                               Antal aktier   ägarandel

Håkan Svanberg & Co Health Care AB                                                   5 070 982      32,15%
Mastan AB (Håkan Lagerberg genom bolag)                                              2 105 362      13,35%
JCC Group Invest Sweden AB (Johan Bergdahl genom bolag)                              2 102 351      13,33%
Swedia Capital AB                                                                      800 786       5,08%
AMF Aktiefond Småbolag                                                                 755 000       4,79%
Aktia Nordic Micro Cap                                                                 516 614       3,28%
SHB Fonder                                                                             480 000       3,04%
Avanza                                                                                 319 753       2,03%
Nordnet Pensionsförsäkring AB                                                          319 600       2,03%
Martin Shimko - VD Swedencare USA                                                      300 000       1,90%
ML, Pierce Fenner & Smith Inc.                                                         222 173       1,41%
Grandeur, Fund BBHBOS                                                                  217 778       1,38%
Granit Fonder Småbolag                                                                 216 265       1,37%
Hans Persson - VD Swedencare Frankrike                                                 199 750       1,27%
Grenspecialisten                                                                       197 454       1,25%
KBC Securities (Ecuphar NV)                                                            195 122       1,24%
Tedcap AB (Thomas Eklund genom bolag)                                                  193 459       1,23%
Lin Micka                                                                              150 772       0,96%
Per Malmström Consulting AB                                                            123 000       0,78%
Anders Lönner                                                                          109 066       0,69%

Övriga                                                                               1 175 335       7,45%

Totalt                                                                              15 770 622     100,00%

Free Float*                                                                           6 175 468     39,16%
Innehav inkluderar närstående
* Aktier som inte ägs av styrelsemedlemmar, deras närstående, eller aktieägare med mer än 10%
Priorities in 2018
• Dental Care Bones
• Expanding NutriScience range
• China launch
• Co-ops with feed partners
• Review acquisition opportunities
• Digital presence and marketing support
• Further strengthen partnerships with major
  players in Vet- and Pet Specialty retailers
Financial Strategy long term
                       Sales Forecast Trend
250

200

150

                    2017 ACTUAL 86M
100
                                 Budget 2017: 80M

50

 0
      2015   2016         2017             2018     2019   2020
You can also read